Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.73 is 53% below its 5-year average of 5.87, near the low end of its 5-year range (0.69–12.76).
As of the fiscal period ended Tuesday, June 30, 2026. 46.58% below its 12-month average of 5.11.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.73.
QUICK RATIO (ACID-TEST)
2.73
QUICK RATIO (ACID-TEST) AVG TTM
5.11
QUICK RATIO (ACID-TEST) AVG 3Y
4.49
QUICK RATIO (ACID-TEST) AVG 5Y
5.87
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-46.58%
CURRENT VS 3Y AVG
-39.19%
CURRENT VS 5Y AVG
-53.49%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.01
median of 677 covered companies
CURRENT VS SECTOR MEDIAN
-9.26%
vs the sector median at left
Dermata Therapeutics, Inc.
Market Cap
$4.55M
Quick Ratio (Acid-Test)
2.73
TTM Avg
5.11
3Y Avg
4.49
5Y Avg
5.87
Market Cap
$4.68M
Quick Ratio (Acid-Test)
7.22
TTM Avg
2.13
3Y Avg
2.10
5Y Avg
5.04
Market Cap
$4.40M
Quick Ratio (Acid-Test)
40.30
TTM Avg
26.48
3Y Avg
43.98
5Y Avg
50.08
Market Cap
$4.33M
Quick Ratio (Acid-Test)
1.35
TTM Avg
3.30
3Y Avg
6.18
5Y Avg
6.77
Market Cap
$4.86M
Quick Ratio (Acid-Test)
10.60
TTM Avg
4.75
3Y Avg
13.37
5Y Avg
23.75
Market Cap
$4.22M
Quick Ratio (Acid-Test)
1.95
TTM Avg
2.83
3Y Avg
3.75
5Y Avg
3.40
Market Cap
$4.12M
Quick Ratio (Acid-Test)
0.87
TTM Avg
1.88
3Y Avg
4.97
5Y Avg
8.67
Market Cap
$4.98M
Quick Ratio (Acid-Test)
5.58
TTM Avg
4.46
3Y Avg
3.04
5Y Avg
7.15
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | $4.55M | 2.73 | 5.11 | 4.49 | 5.87 |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.68M | 7.22 | 2.13 | 2.10 | 5.04 |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.40M | 40.30 | 26.48 | 43.98 | 50.08 |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.33M | 1.35 | 3.30 | 6.18 | 6.77 |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.86M | 10.60 | 4.75 | 13.37 | 23.75 |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.22M | 1.95 | 2.83 | 3.75 | 3.40 |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.12M | 0.87 | 1.88 | 4.97 | 8.67 |
| GRI Bio, Inc. (GRI)vs › | $4.13M | 10.30 | 3.34 | 1.98 | 1.38 |
| CalciMedica, Inc. (CALC)vs › | $4.98M | 5.58 | 4.46 | 3.04 | 7.15 |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.08M | 2.01 | 0.91 | 1.26 | 1.78 |
Quick Ratio
2.73
Excludes inventory
Current Ratio
2.81
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.73 |
| 2026-03-31 | 7.00 |
| 2025-12-31 | 4.79 |
| 2025-09-30 | 4.56 |
| 2025-06-30 | 6.47 |
| 2025-03-31 | 3.70 |
| 2024-12-31 | 1.79 |
| 2024-09-30 | 3.44 |
| 2024-06-30 | 2.73 |
| 2024-03-31 | 3.78 |
| 2023-12-31 | 4.91 |
| 2023-09-30 | 7.99 |
| 2023-06-30 | 12.76 |
| 2023-03-31 | 7.70 |
| 2022-12-31 | 7.53 |
| 2022-09-30 | 5.97 |
| 2022-06-30 | 8.07 |
| 2022-03-31 | 7.59 |
| 2021-12-31 | 7.66 |
| 2021-09-30 | 11.45 |
| 2021-06-30 | 0.69 |
| 2021-03-31 | 1.76 |
| 2020-12-31 | 0.16 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
